Clinical Trials Logo

Glycemic Control clinical trials

View clinical trials related to Glycemic Control.

Filter by:

NCT ID: NCT05460884 Active, not recruiting - Healthy Subjects Clinical Trials

Effects of Seaweed Extract on Postprandial Response to White Bread

Start date: September 12, 2020
Phase: N/A
Study type: Interventional

The study is designed to determine whether seaweed extract added to a carbohydrate-rich meal, can lower blood glucose levels after its consumption, and hence lower its glycaemic index, and if this effect is mediated through effects on insulin. It is designed as an acute, randomised, cross-over, controlled, three-arm dietary intervention trial in healthy subjects. Participants will be asked to consume either white bread, white bread with lower dose of seaweed extract or white bread with higher dose of seaweed extract.The effects on plasma glucose levels and levels of insulin will be determined over 3 hours after the consumption.

NCT ID: NCT05394727 Recruiting - Clinical trials for Gestational Diabetes

Application of Needle-free Injection of Insulin in Patients With Gestational Diabetes Mellitus

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

This study is about the application of needle-free injection device in GDM patients in order to observe the variation of blood glucose and patients' experience compared to the traditional insulin pen injection. To provide evidence for the application of needle-free syringe injection in GDM patients.

NCT ID: NCT05279183 Completed - Appetite Clinical Trials

Assessment of Reward Responses to Erythritol Using Flavor Preference Learning

Start date: March 17, 2022
Phase: N/A
Study type: Interventional

The aim of this project is to investigate the reward responses to oral erythritol compared to sucrose and sucralose using flavor preference learning in healthy participants. In addition, the release of GI hormones, glycemic control, appetite-related sensations, and emotional state in response to erythritol will be investigated.

NCT ID: NCT05166200 Completed - Glycemic Control Clinical Trials

Glycemic Response in Adults With Type 2 Diabetes

Start date: March 11, 2022
Phase: N/A
Study type: Interventional

This is a randomized, controlled, crossover study to compare the effects of two treatments on postprandial glucose in adults with type 2 diabetes.

NCT ID: NCT05165693 Completed - Glycemic Control Clinical Trials

Evaluation of Glycemic Response in Individuals With Type 2 Diabetes

Start date: February 23, 2022
Phase: N/A
Study type: Interventional

This is a randomized, controlled, crossover study to compare the effects to two treatments on postprandial glucose in adults with type 2 diabetes.

NCT ID: NCT05154045 Completed - Glycemic Control Clinical Trials

Postprandial Glycemic Response in Adults With Type 2 Diabetes

Start date: April 9, 2022
Phase: N/A
Study type: Interventional

This is a randomized, controlled, crossover study to compare the effects of two treatments on postprandial glucose in adults with type 2 diabetes.

NCT ID: NCT05115682 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

Circadian Rhythm and Metabolic Effects of Exercise

HITMet
Start date: November 10, 2021
Phase: N/A
Study type: Interventional

Physical exercise is efficacious in controlling blood glucose levels in individuals with Type 2 diabetes. An individual's exercise capacity and ability to utilize glucose as an energy source oscillates throughout the day. Hence, the beneficial effects of exercise on blood glucose levels may depend on the time of day when the exercise bout is performed. However, the time of day in which the most beneficial adaptations to exercise can be achieved remains unknown. This project aims to answer the following questions: Does time of day impact the beneficial effects of exercise on blood glucose? If so, when can the most beneficial effects of exercise be achieved? Which metabolic mechanisms links time of day, exercise and blood glucose control? To address these questions, individuals with or without Type 2 diabetes will perform an exercise session at two different times (09:00 and 16:00), and continuous glucose monitoring will be used to assess the effects of exercise on blood glucose. We will determine the specific metabolic processes which promote the most beneficial blood glucose response. To achieve this, we will measure which metabolic substrates (carbohydrates, lipids and proteins) are used and which metabolites produced in blood, skeletal muscle and adipose tissue in response to exercise at different times of the day.

NCT ID: NCT04994327 Completed - PreDiabetes Clinical Trials

Bread Replacement - Facing the Challenge to Improve Its Quality for Better Metabolic Health

Start date: May 7, 2021
Phase: N/A
Study type: Interventional

This is a multicenter study testing the effect of bread containing beta-glucan on glycemic control in participants with intermediate hyperglycemia. The main hypothesis of the study is that bread enriched with beta-glucan will have a positive effect on blood glucose control (HbA1c) in persons with intermediate hyperglycemia. Bread (intervention and control) will be produced by Nofima (Ås, Norway) using food-grade beta-glucan from oat and barley and shipped to the study centers (Bergen (N), Gothenburg (S), Paderborn, and Leipzig (D)) and there distributed for free to the participants of the study. The study will last for 16 weeks with measurements at baseline, after 8 weeks and after 16 weeks. Blood and urine samples will be taken, anthropometry and body composition measured, and questionnaires on health status and socio-economic status, physical activity, nicotine use, alcohol habits, chronotype, quality of life, and consumer acceptance of the study bread will be filled in.

NCT ID: NCT04848233 Completed - Glycemic Control Clinical Trials

Using CGM for Evaluating Effects of Food on Glucose Regulation in Healthy Humans

Start date: April 20, 2021
Phase: N/A
Study type: Interventional

The specific goal of this pilot study is to evaluate if it is possible to detect a statistical difference in postprandial glycemia after meals served with and without a drink previously shown to reduce postprandial glycemia by about 25%. A third drink, with a new recipe, is also included for comparisons. Six participants will carry continuous blood glucose monitors for 10 days and follow a specific meal schedule. The data from this study will form the basis for forming hypothesis of future studies as well as make appropriate calculations of statistical power.

NCT ID: NCT04821752 Recruiting - Glucose Intolerance Clinical Trials

Environmental Toxicants Avoidance Study

NPETA-GD
Start date: May 1, 2022
Phase: N/A
Study type: Interventional

This study is designed to test whether non-persistent environmental chemicals (PECs) are elevated in people with glucose dysregulation. The primary aim is to measure whether this toxicant burden can be reduced using a dietary and lifestyle modification intervention. The secondary aim is to observe any changes in glucose response pre and post-intervention.